Entero Therapeutics, Inc. (GRDX) — Free Cash Flow Generation Index

Latest as of June 2014: 1.00x

Entero Therapeutics, Inc. (GRDX) has a Free Cash Flow Generation Index of 1.00x as of June 2014. Free cash flow of $129.24 represents 1% of operating cash flow ($129.24). See GRDX working capital ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

$129.24
USD

Operating Cash Flow

$129.24
USD

Capital Expenditures

$0.00
USD

Entero Therapeutics, Inc. Free Cash Flow Generation Index (2013–2013)

Historical FCF Generation Index trend for Entero Therapeutics, Inc. across 1 annual periods. Explore Entero Therapeutics, Inc. cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Entero Therapeutics, Inc. (2013–2013)

Year-by-year Free Cash Flow Generation Index for Entero Therapeutics, Inc.. For the full company profile including market capitalisation, see GRDX market cap.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2013 1.00x $56.55 $56.55 $0.00
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).